Compound Detail
CHEMBL5564851
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5564851 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | MXMZKVJUEAPGJP-UHFFFAOYSA-N |
1
Targets
2
Activities
2
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
245.3
MW (Da)
1.51
ALogP
4
HBA
3
HBD
82.9
PSA (Ų)
0.55
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 4.21
Kd 1 meas.
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Internal ribosome entry site (IRES) CHEMBL612412 | EC50 | 4.21 | 4.21 | 61000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Internal ribosome entry site (IRES) | EC50 | = | 61000.0 | nM | 4.21 | Binding affinity to HCV IRES subdomain IIa RNA assessed as reduction in FRET sig... | 38784459 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 38784459 | 10.1039/d3md00696d | Internal ribosome entry site (IRES) | 2 |
Data from ChEMBL 36 via Core Engine